Literature DB >> 328032

Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans.

K F Tempero, V J Cirillo, S L Steelman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 328032      PMCID: PMC1428837          DOI: 10.1111/j.1365-2125.1977.tb04511.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

Authors:  T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  SALICYLATE OTOTOXICITY: A CLINICAL STUDY.

Authors:  E N MYERS; J M BERNSTEIN; G FOSTIROPOLOUS
Journal:  N Engl J Med       Date:  1965-09-09       Impact factor: 91.245

3.  Reappraisal of the hypoglycemic action of acetylsalicylate.

Authors:  A HECHT; M G GOLDNER
Journal:  Metabolism       Date:  1959-07-01       Impact factor: 8.694

4.  Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.

Authors:  D J Tocco; G O Breault; A G Zacchei; S L Steelman; C V Perrier
Journal:  Drug Metab Dispos       Date:  1975 Nov-Dec       Impact factor: 3.922

Review 5.  Nonsteroid anti-inflammatory agents.

Authors:  H E Paulus; M W Whitehouse
Journal:  Annu Rev Pharmacol       Date:  1973       Impact factor: 13.820

6.  Inhibition of prostaglandin synthesis in man.

Authors:  M Hamberg
Journal:  Biochem Biophys Res Commun       Date:  1972-11-01       Impact factor: 3.575

7.  Effects of large and small doses of hydrochlorothiazide in hypertensive patients.

Authors:  P J McLeod; R I Ogilvie; J Ruedy
Journal:  Clin Pharmacol Ther       Date:  1970 Sep-Oct       Impact factor: 6.875

8.  Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.

Authors:  M Hamberg; J Svensson; T Wakabayashi; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1974-02       Impact factor: 11.205

9.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Authors:  M Hamberg; J Svensson; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

  9 in total
  17 in total

Review 1.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 2.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

Review 3.  Single dose oral diflunisal for acute postoperative pain in adults.

Authors:  Jack O Wasey; Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

4.  Failure of alkaline diuresis to enhance diflunisal elimination.

Authors:  M Balali-Mood; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-08       Impact factor: 4.335

Review 5.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 6.  Ototoxicity associated with salicylates. A brief review.

Authors:  J A Brien
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

Review 7.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 8.  Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis.

Authors:  R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-02       Impact factor: 9.546

Review 9.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

10.  Diflunisal protects human gastric mucosa against damage by indomethacin.

Authors:  M M Cohen
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.